Dayforce recognized for Ability to Execute and Completeness of VisionMINNEAPOLIS and TORONTO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced it has been named a Leader in the 2025 Gartner Magic Quadrant for HCM Suites for 1,000+ Employees Enterprises. Dayforce was recognized for the sixth consecutive year, driven by Dayforce’s Ability to Execute and Completeness of Vision. Operating across N ...

FINANCIAL PRESS RELEASE FIRST-HALF 2025 RESULTS A performance that translates into a slight improvement in net income Consolidated revenue stable at €109.3m (-0.2%)+€0.5m increase in Group net income Reims, September 11, 2025The Board of Directors of Vranken-Pommery Monopole met on September 11, 2025 under the chairmanship of Mrs. Nathalie Vranken, and in the presence of the Statutory Auditors, to approve the Group's financial statements for the half year 2025.The limited review procedures on the half-year ...

Tonner Drones announces the launch of a capital increase with preferential subscription rights in the form of ABSA for a maximum amount of approximately 1 million euros Maximum amount of approximately 1 million euros through a capital increase with preferential subscription rights (“DPS”) in the form of new shares accompanied by share subscription warrants (“BSA 2025-1”) (“ABSA”)Subscription parity: 1 ABSA for 14 existing sharesSubscription price: 0.027 euros for an ABSAThe BSA 2025-1 will give the right to ...

The esteemed ranking celebrates ASUS for outstanding performance in employee satisfaction, revenue growth, and sustainable practicesKEY POINTS TIME recognition: ASUS secures its second inclusion on TIME’s World’s Best Companies that set the standard in innovation, growth, employee satisfactionA commitment to innovation: ASUS validated for its leadership in fostering a great workplace, driving business growth, and advancing sustainabilityGlobal distinction: ASUS continues to receive worldwide acclaim from es ...

合同核心信息 - 公司获得巴西国家石油公司Petrobras重大合同 通过竞争性招标流程为2026至2029年海上作业提供OCTG产品和服务 [1] - 长期协议可能产生高达10亿美元总收入 这是Petrobras采用公开招标策略以来规模最大合同 [1] 产品与服务范围 - 合同涵盖全范围OCTG供应 包括4.5英寸至18英寸无缝管和VAM高级连接件 含碳钢和不锈钢管材及相关配件 [2] - 公司将提供综合增值服务 包括陆上和海上服务 从桌面工程 材料协调到钻井平台准备 海上监督 钻具修复和重新入库 [2] 市场地位与合作伙伴关系 - 此次成功巩固了VAM高级连接件和公司管材服务在巴西市场的领导地位 [3] - 合作关系基于技术卓越性 在巴西的综合工业存在以及与Petrobras长期互信的合作关系 [4] 公司背景 - 公司是全球能源市场和苛刻工业应用领域高级管材解决方案的领导者 业务涵盖恶劣环境油气井 新一代发电厂 高难度建筑项目和高性能机械设备 [5] - 公司拥有近14,000名员工 遍布20多个国家 致力于提供创新 安全 竞争力和智能的管材解决方案 [5] 企业治理与投资者信息 - 公司在巴黎泛欧交易所上市 ISIN代码为FR0013506730 股票代码为VK 是CAC Mid 60 SBF 120和Next 150指数成分股 [6] - 公司在美国建立了赞助级第一级美国存托凭证计划 ISIN代码为US92023R4074 股票代码为VLOWY ADR与普通股设定为5:1的兑换比例 [6]

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1993, AS AMENDED (THE “SECURITIES ACT”)) OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE US VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UN ...

核心观点 - OSE Immunotherapeutics与FoRT基金会联合宣布完成Combi-TED二期临床试验患者招募 该试验评估Tedopi®联合纳武利尤单抗或多西他赛治疗非小细胞肺癌的疗效[1] - 试验共纳入105例HLA-A2阳性转移性非小细胞肺癌患者 主要终点为1年生存率 顶线结果预计2026年下半年公布[3][8] 试验设计 - 采用开放标签、随机、三臂设计：Tedopi®联合纳武利尤单抗、Tedopi®联合多西他赛、多西他赛单药对照组[3] - 针对一线化疗免疫治疗后进展且无EGFR/ALK/ROS1突变的转移性非小细胞肺癌患者[3] - 试验由意大利FoRT基金会主导 在意大利、法国和西班牙的多中心开展[2] 临床开发战略 - Combi-TED试验旨在探索Tedopi®联合免疫治疗或化疗在更广泛转移性非小细胞肺癌人群中的应用价值[5] - 公司同步推进Tedopi®单药 versus 多西他赛的ARTEMIA关键试验 针对免疫检查点抑制剂继发耐药患者[5] - 该策略基于ATALANTE-1研究的积极结果 旨在解决二线治疗未满足的医疗需求[5] 技术机制 - Tedopi®是一种基于新表位的治疗性癌症疫苗 通过激活T淋巴细胞增强免疫检查点抑制剂或化疗疗效[4] - 联合治疗方案针对一线化疗免疫治疗≥3个月（四个周期）后进展且适合多西他赛治疗的患者群体[4][11] 公司背景 - OSE Immunotherapeutics专注于免疫肿瘤和免疫炎症领域首创疗法的开发[6] - 公司与领先学术机构和生物制药公司建立合作伙伴关系 总部位于南特和巴黎 在泛欧交易所上市[6]

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11 Date Total number of shares composing the share capital Total number of voting rights (1) 31 August 2025 83,814,526 Gross total* of voting rights: 132,062,873 Net total** ...

RELEASE Paris, September 11, 2025 INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPRISING THE SHARE CAPITAL In accordance with the provisions of Article L. 233-8 of the French Commercial Code (Code de commerce) and Article 223-16 of the General Regulations of French Autorité des Marchés Financiers (AMF), Hermès international publishes each month, before the 15th day of the following month, the total number of voting rights and the number of shares comprising the share capital if they ...

Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Paris, France (September 11, 2025 - 6:00 pm) – As of August 31, 2025, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below. Augus ...